Ftse Mib
37.834,52
0,81%
DAX
22.526,18
1,73%
S&P 500
6.078,68
0,44%
NASDAQ
19.763,19
0,58%
Bitcoin
95.972,26
-1,97%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TriSalus Life Sciences Inc (TLSI) TriSalus Life Sciences Inc (TLSI) Notizie

TLSI

TriSalus Life Sciences (TLSI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TLSI
DataOraFonteTitoloSimboloCompagnia
10/01/202512:47Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TLSITriSalus Life Sciences Inc
14/11/202414:00Business WireTriSalus Reports Q3 2024 Financial Results and Provides Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
11/11/202413:00Business WireTriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver CancerNASDAQ:TLSITriSalus Life Sciences Inc
07/11/202413:00Business WireTriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor TreatmentNASDAQ:TLSITriSalus Life Sciences Inc
31/10/202413:00Business WireTriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
14/10/202422:05Business WireTriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:TLSITriSalus Life Sciences Inc
26/09/202413:00Business WireTriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory BoardNASDAQ:TLSITriSalus Life Sciences Inc
23/09/202413:00Business WireTriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion SystemNASDAQ:TLSITriSalus Life Sciences Inc
15/08/202414:00Business WireTriSalus Reports Q2 2024 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
01/08/202413:00Business WireTriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
01/07/202422:00Business WireTriSalus Life Sciences Announces Completion of Exchange Offer and Consent SolicitationNASDAQ:TLSITriSalus Life Sciences Inc
26/06/202423:45Business WireTriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to WarrantsNASDAQ:TLSITriSalus Life Sciences Inc
03/06/202413:00Business WireTriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual MeetingNASDAQ:TLSITriSalus Life Sciences Inc
24/05/202412:05Business WireTriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to WarrantsNASDAQ:TLSITriSalus Life Sciences Inc
15/05/202414:00Business WireTriSalus Reports Q1 2024 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
07/05/202413:00Business WireTriSalus Life Sciences Appoints Liselotte Hyveled to its Board of DirectorsNASDAQ:TLSITriSalus Life Sciences Inc
06/05/202422:58Business WireTriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
30/04/202422:35Business WireTriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth InitiativesNASDAQ:TLSITriSalus Life Sciences Inc
01/04/202414:00Business WireTriSalus Reports Q4 and Full Year 2023 Financial Results and Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
26/03/202413:00Business WireTriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
21/03/202413:00Business WireTriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific MeetingNASDAQ:TLSITriSalus Life Sciences Inc
11/03/202422:15Business WireTriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial ResultsNASDAQ:TLSITriSalus Life Sciences Inc
07/03/202413:00Business WireTriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for “Nelitolimod” as the Nonproprietary Drug Name for SD-101NASDAQ:TLSITriSalus Life Sciences Inc
29/02/202413:00Business WireTriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver TumorsNASDAQ:TLSITriSalus Life Sciences Inc
15/02/202400:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLSITriSalus Life Sciences Inc
25/01/202423:23Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TLSITriSalus Life Sciences Inc
25/01/202423:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLSITriSalus Life Sciences Inc
27/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TLSITriSalus Life Sciences Inc
14/11/202314:00Business WireTriSalus Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TLSITriSalus Life Sciences Inc
07/11/202322:05Business WireTriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference CallNASDAQ:TLSITriSalus Life Sciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TLSI

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
TIT
Telecom Italia
BIT
BAMI
Banco BPM
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
RACE
Ferrari NV
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
TITR
Telecom Italia
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci